NSSG Chemotherapy Protocol

CYCLOPHOSPHAMIDE / BORTEZOMIB/ …

Myeloma group This is a controlled document and therefore must not be changed of MM.11 CyBorDex- Amyloidosis Authorised by …

  Cybordex amyloidosis, Cybordex, Amyloidosis

Cyclophosphamide priming prior to PBSC harvest

Department of Clinical Haematology Oxford BMT Programme B.2.20b Page 1 of 3 May 2017 V.5.4 Cyclo prime for Myeloma PSBC Harvest Authorised by: Dr Karthik Ramasamy

  2017, Myeloma

ATTENUATED CYCLOPHOSPHAMIDE, THALIDOMIDE & …

Myeloma group This is a controlled document and therefore must not be changed MM.9 CTD - attenuated Authorised by Myeloma lead Dr. Karthik Ramasamy July 2017

  Attenuated

Guidelines for the Management of Hypomagnesaemia …

Department of Clinical Haematology H.95 Page 2 of 5 November 2015 V.1.0. Guidelines for the management of hypomagnesaemia in Adult Clinical Haematology

  Management, Hypomagnesaemia, For the management of hypomagnesaemia

Oxford Myeloma Group

MM.50 VTDPACE/DTPACE Authorised by Myeloma lead Dr. Karthik Ramasamy June 2022 V. 2.0 of 10 Days Drug Dose Route Comments 1 to 4 Dexamethasone 40 mg daily Oral Continuous daily/ If PBSC harvest planned only for days 1 to 4 Thalidomide (See note below) Start 50 mg and increase up to 100 mg as tolerated Oral Nocte 1 to 4

  Group, Myeloma, 50 mg, Myeloma group

MATRix (High dose METHOTREXATE, high dose CYTARABINE ...

- Reduce thiotepa dose to 75% - Reduce methotrexate to 2g/m2 Haematological toxicity In case if inadequate bone marrow recovery (i.e. neutrophils < 1.5x109/L and platelets < 90x109/L on the intended day of re-treatment, delay cycle until counts satisfactory. Doses of the chemotherapy

  Thiotepa

ISATUXIMAB WITH POMALIDOMIDE AND …

volume Initial rate Absence of infusion reaction Rate increment Maximum rate First infusion 250 mL 25 mL/ hour For 60 minutes 25 mL/hour every 30 minutes 150 mL/ hour Second infusion 250 mL 50 mL/ hour For 30 minutes 50 mL/ hour for 30 minutes then increase by 100 mL/ hr every 30 minutes 200 mL/ hour Subsequent infusions

  With, Volume, Increment, Pomalidomide, Isatuximab with pomalidomide and, Isatuximab

ATRA + ARSENIC TRIOXIDE

Arsenic Trioxide infusion duration may be extended up to 4 hours if vasomotor reactions, e.g. flushing, tachycardia and dizziness, are observed. If patients suffer severe symptoms or hypotension then the infusion should be stopped until recovery and then recommenced at a

  Trioxide

High dose METHOTREXATE (high grade NHL CNS …

adults receiving high-dose methotrexate chemotherapy (doses >1g/m2) - Who develop significant deterioration in renal function (>1.5x ULN and rising, or the presence of oliguria) OR - Have toxic plasma methotrexate level AND - Have been treated with all standard rescue and supportive measures AND

  High, Grade, Dose, Chemotherapy, Methotrexate, High dose methotrexate, High grade nhl cns

ESHAP and R-ESHAP

2. Record stage of disease - contrast enhanced CT scan (neck, chest, abdomen and pelvis), ... In order to eliminate the risk of transmitting infective ... After 1-2 cycles with CT or PET-CT. Lymphoma group This is a controlled document and therefore must …

  Order, Enhanced, Contrast, Contrast enhanced ct

Ionic Charges Chart (Cations and Anions) Cations

amide NH 2-cyanate OCN-hydrogen carbonate fluoride F-(bicarbonate) HCO 3-hydride H-hydrogen sulfate hydroxide OH-(bisulfate) HSO 4-hypochlorite ClO-bisulfide HS-iodate IO 3-bisulfite HSO 3 -iodide I-bromate BrO 3-nitrate NO 3-bromide ...

  Media

pKa Values INDEX - Organic Chemistry Data

pKa Data Compiled by R. Williams ACIDS Compound pK Ref. H3PO2 2.0, 2.23* 28 H2PO4– 7.21* 77 AgOH 3.96 4 HPO4_ 12.32* 77 Al(OH)3 11.2 28 As(OH) H3PO3 2.0 28 3 9.22 28 H3AsO4 2.22, 7.0, 13.0 28 H2PO3– 6.58* 77

Christian Tondeleir

Toen ben je zomaar ingeslapen, stil en discreet, alsof je niemand wilde storen. Met deze woorden nemen we afscheid van de heer Christian Tondeleir